A phase II trial of gemcitabine and weekly high-dose 5-fluorouracil in a 48-hour continuous-infusion schedule in patients with advanced pancreatic carcinoma. A study of the Spanish Cooperative Group for Gastrointestinal Tumour Therapy (TTD).

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Volumn 7, Issue 11, 2005, Pages 493-498

  Santasusana, Joan Maurel ^a   García López, José Luis ^a   García, Juan José ^a   Carbonero, Ana Isabel León ^a   Plazas, Javier Gallego ^a   Rovira, Pedro Sánchez ^a   Martos, Carlos Fernández ^a   Guzmán, M Carmen Galán ^a   Jericó, Jesús Florián ^a   Delgado, Francisco Javier Dorta ^a   Espinosa, Javier Casinello ^a   Muñoz, Marta Llanos ^a   Aguilar, Enrique Aranda ^a   Valera, Javier Sastre ^a   García Ribas, Ignacio ^a   Mena, Alfredo Carrato ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE; FLUOROURACIL; GEMCITABINE;

ADULT; AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DISEASE FREE SURVIVAL; DRUG ADMINISTRATION; FEMALE; FOLLOW UP; HUMAN; HYPERBILIRUBINEMIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; MUCOSA INFLAMMATION; MULTICENTER STUDY; NEUTROPENIA; PANCREAS TUMOR; PATHOLOGY; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; QUALITY OF LIFE; SPAIN; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; HYPERBILIRUBINEMIA; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MUCOSITIS; NEUTROPENIA; PANCREATIC NEOPLASMS; PATIENT COMPLIANCE; QUALITY OF LIFE; SPAIN; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33645253810     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02717002     Document Type: Article

References (0)